UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2021~~ 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 001-39728

Cascade Acquisition Corp.

(Exact name of registrant as specified in its charter)

Delaware

85-2562068

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1900 Sunset Harbour Dr., Suite 2102
Miami Beach, Florida 33139

(Address of Principal Executive Offices, including zip code)

(203) 856-3033

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share	CAS	New York Stock Exchange
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock for $11.50 per share	CAS.WS	New York Stock Exchange
Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant	CAS.U	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐	Large accelerated filer	☐	Accelerated filer
☒	Non-accelerated filer	☒	Smaller reporting company
		☒	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒ No ☐

As of ~~November~~May 1520, ~~2021~~2022, there were 23,000,000 shares of Class A common stock, par value $0.0001 per share, and 5,750,000 shares of Class B common stock, par value $0.0001 per share, of the registrant issued and outstanding.

CASCADE ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED ~~SEPTEMBER~~MARCH 3031, ~~2021~~ 2022

TABLE OF CONTENTS

	Page	~~Page~~
Part I. Financial Information
Item 1. Financial Statements
Condensed Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020		1
Condensed Balance Sheets as of March 31, 2022 (Unaudited) and December 31, 2021	1
Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2021 and for the Period from August 14, 2020 (Inception) through September 30, 2020 (Unaudited)		2
Condensed Statements of Operations for the Three Months Ended March 31, 2022 and 2021 (Unaudited)	2
Condensed Statements of Changes in Stockholder’s (Deficit) Equity for the Three and Nine Months Ended September 30, 2021 and for the Period from August 14, 2020 (Inception) through September 30, 2020 (Unaudited)		3
Condensed Statements of Changes in Stockholders’ Deficit for the Three Months Ended March 31, 2022 and 2021 (Unaudited)	3
Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2021 and for the Period from August 14, 2020 (Inception) through September 30, 2020 (Unaudited)		4
Condensed Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021 (Unaudited)	4
Notes to Condensed Financial Statements (Unaudited)	5	5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	19	20
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk	24	25
Item 4. Controls and Procedures	24	25
Part II. Other Information
Item 1. Legal Proceedings	25	27
Item 1A. Risk Factors	25	27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	26	27
Item 3. Defaults Upon Senior Securities	26	27
Item 4. Mine Safety Disclosures	26	27
Item 5. Other Information	26	27
Item 6. Exhibits	27	28
Signatures	28	29

Part I. Financial Information

Item 1. Financial Statements

CASCADE ACQUISITION CORP.

CONDENSED BALANCE SHEETS

	September 30, 2021			December 31, 2020
	March 31, 2022			December 31, 2021
	(Unaudited)			~~(Restated)~~
ASSETS
Cash	$	~~479~~161,~~978~~294		$	1379,~~277,708~~046
Prepaid expenses		~~190~~99,~~688~~500			~~285~~130,~~823~~667
Total current assets		~~670~~260,~~666~~794			1509,~~563,531~~713
Marketable securities held in Trust Account		232,~~382~~393,~~820~~324			232,~~296~~387,~~529~~376
TOTAL ASSETS	$	~~233~~232,~~053~~654,~~486~~118		$	~~233~~232,~~860~~897,~~060~~089
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities – accounts payable and accrued expenses	$	~~896~~1,~~244~~389,934		$	881,~~747~~041,832
Warrant liabilities		123,~~635~~549,~~390~~060			269,~~815~~858,~~120~~500
Deferred underwriting fee payable		6,854,750			6,854,750
TOTAL LIABILITIES		2011,~~386~~793,~~384~~744			3317,~~758~~755,~~617~~082
Commitments and Contingencies
Temporary Equity
Class A common stock, $0.0001 par value, subject to possible redemption, 23,000,000 shares at redemption value of $10.10 at September 30, 2021 and December 31, 2020		232,300,000			232,300,000
Class A common stock, $0.0001 par value, subject to possible redemption, 23,000,000 shares at redemption value of $10.10		232,300,000			232,300,000
Stockholders’ Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding		—			—
Class A common stock, $0.0001 par value, 200,000,000 shares authorized (excluding 23,000,000 shares subject to possible redemption at September 30, 2021 and December 31, 2020)		—			—
Class A common stock, $0.0001 par value, 200,000,000 shares authorized (excluding 23,000,000 shares subject to possible redemption)		—			—
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding at September 30, 2021 and December 31, 2020		575			575
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding		575			575
Accumulated deficit		(1911,~~633~~440,~~473~~201	)		(3217,~~199~~158,~~132~~568	)
Total Stockholders’ Deficit		(1911,~~632~~439,~~898~~626	)		(3217,~~198~~157,~~557~~993	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	~~233~~232,~~053~~654,~~486~~118		$	~~233~~232,~~860~~897,~~060~~089

The accompanying notes are an integral part of the unaudited condensed financial statements.

CASCADE ACQUISITION CORP.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three Months Ended September 30, 2021			Nine Months Ended September 30, 2021			For the Period from August 14, 2020 (Inception) Through September 30, 2020
	Three Months Ended March 31,
Formation and operating costs	$	302,787		$	1,700,362		$	882
	2022			2021
Loss from operations		(302,787	)		(1,700,362	)		(882	)
Formation and operating costs	$	684,021		$	330,701
Other income:
Loss from operations		(684,021	)		(330,701	)
Interest earned on marketable securities held in Trust Account		2,990			86,291			—
Other income:
Change in fair value of warrant liabilities		7,163,780			14,179,730			—
Interest earned on marketable securities held in Trust Account		80,637			58,062
		7,166,770			14,266,021			—
Unrealized gain on marketable securities held in Trust Account		12,311			19,592
Net income (loss)	$	6,863,983		$	12,565,659		$	(882	)
Change in fair value of warrant liabilities		6,309,440			9,069,820
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption		23,000,000			23,000,000			—
Total other income		6,402,388			9,147,474
Basic and diluted net income per share, Class A common stock subject to possible redemption	$	0.24		$	0.44		$	—
Net income	$	5,718,367		$	8,816,773
Basic and diluted weighted average shares outstanding, Class B common stock (non-redeemable)		5,750,000			5,750,000			5,000,000
Basic and diluted weighted average shares outstanding, Class A common stock		23,000,000			23,000,000
Basic and diluted net income (loss) per share, Class B common stock (non-redeemable)	$	0.24			0.44		$	(0.00	)
Basic and diluted net income per share, Class A common stock	$	0.20		$	0.31
Basic and diluted weighted average shares outstanding, Class B common stock		5,750,000			5,750,000
Basic and diluted net income per share, Class B common stock	$	0.20			0.31

The accompanying notes are an integral part of the unaudited condensed financial statements.

CASCADE ACQUISITION CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ ~~(DEFICIT)~~ ~~EQUITY~~DEFICIT

(UNAUDITED)

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER 30~~MARCH 31, ~~2021~~2022

	Class B Common Stock				Accumulated			Total Stockholders’
	Shares		Amount		Deficit			Deficit
Balance — December 31, 2020 (restated – see Note 2)		5,750,000	$	575	$	(32,199,132	)	$	(32,198,557	)
Balance — December 31, 2021		5,750,000	$	575	$	(17,158,568	)	$	(17,157,993	)
Net income		—		—		85,~~816~~718,~~773~~367			85,~~816~~718,~~773~~367
Balance – March 31, 2021 (restated – see Note 2)		5,750,000	$	575		(23,382,359	)		(23,381,784	)
Balance – March 31, 2022		5,750,000	$	575	$	(11,440,201	)		(11,439,626	)
Net loss		—		—		(3,115,097	)		(3,115,097	)
Balance – June 30, 2021 (restated – see Note 2)		5,750,000	$	575	$	(26,497,456	)	$	(26,496,881	)
Net income		—		—		6,863,983			6,863,983
Balance – September 30, 2021		5,750,000	$	575	$	(19,633,473	)	$	(19,632,898	)

FOR THE ~~PERIOD~~THREE ~~FROM~~MONTHS ~~AUGUST~~ENDED ~~14,~~MARCH ~~2020 (INCEPTION) THROUGH SEPTEMBER 30~~31, ~~2020~~2021

	Class B Common Stock				~~Additional Paid-in~~Accumulated			~~Accumulated~~Total Stockholders’			~~Total Stockholders’~~
	Shares		Amount		~~Capital~~Deficit			Deficit			~~Equity~~
Balance — August 14, 2020 (Inception)		—	$	—	$	—		$	—		$	—
Balance — December 31, 2020		5,750,000	$	575	$	(32,199,132	)	$	(32,198,557	)
Issuance of Class B common stock to Sponsor		5,750,000		575		24,425			—			25,000
Net income		—		—		8,816,773			8,816,773
Net loss		—		—		—			(882	)		(882	)
Balance – March 31, 2021		5,750,000	$	575	$	(23,382,359	)		(23,381,784	)
Balance – September 30, 2020		5,750,000	$	575	$	24,425		$	(882	)	$	24,118

The accompanying notes are an integral part of the unaudited condensed financial statements.

CASCADE ACQUISITION CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Nine Months Ended September 30,			For the Period from August 14, 2020 (Inception) through September 30,
	Three Months Ended March 31,
	2021			2020
	2022			2021
Cash Flows from Operating Activities:
Net income (loss)	$	12,565,659		$	(882	)
Net income	$	5,718,367		$	8,816,773
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(8680,~~291~~637	)		—(58,062	)
Change in fair value of warrant liabilities		(14,179,730	)		—
Unrealized gain on marketable securities held in Trust Account		(12,311	)		(19,592	)
Change in fair value of warrant liabilities		(6,309,440	)		(9,069,820	)
Changes in operating assets and liabilities:
Prepaid expenses		9531,~~135~~167			—43,785
Accounts payable and accrued expenses		~~807~~348,~~497~~102			~~878~~117,286
Net cash used in operating activities		(~~797~~304,~~730~~752	)		(4169,630	)
Cash Flows from Financing Activities:
Cash Flows from Investing Activities:
Proceeds from issuance of Class B common stock to Sponsor		—			25,000
Cash withdrawn from Trust Account to pay franchise taxes		87,000			—
Proceeds from promissory note – related party		—			141,075
Net cash provided by financing activities		87,000			—
Repayment of convertible promissory note – related party		—			(141,075	)
Net Change in Cash		(217,752	)		(169,630	)
Net cash provided by financing activities		—			25,000
Cash – Beginning		379,046			1,277,708
Net Change in Cash		(797,730	)		24,996
Cash – Ending	$	161,294		$	1,108,078
Cash – Beginning		1,277,708			—
Cash – Ending	$	479,978		$	24,996
Non-cash investing and financing activities:
Offering costs included in accrued offering costs	$	—		$	36,367

The accompanying notes are an integral part of the unaudited condensed financial statements.

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Cascade Acquisition Corp. (the “Company”) was incorporated in Delaware on August 14, 2020. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”).

The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of ~~September~~March 3031, ~~2021~~2022, the Company had not commenced any operations. All activity for the period from August 14, 2020 (inception) through March ~~September 30~~31, ~~2021~~2022 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the ~~search~~Initial ~~for~~Public Offering, identifying a target company for ~~its~~a ~~initial~~ Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company ~~generates~~will generate non-operating income in the form of interest income ~~and unrealized gains and losses~~ from the marketable securities held in the Trust Account (as defined below)~~, along with income or loss from the change in fair value of the warrant liabilities~~.

The registration statement for the Company’s Initial Public Offering was declared effective on November 19, 2020. On November 24, 2020, the Company consummated the Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $200,000,000, which is described in Note 43.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,317,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Cascade Acquisition Holdings LLC (the “Sponsor”), generating gross proceeds of $7,317,000, which is described in Note 54.

Following the closing of the Initial Public Offering on November 24, 2020, an amount of $202,000,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.

On December 9, 2020, pursuant to the full exercise of the underwriters’ over-allotment option, the Company consummated the sale of an additional 3,000,000 Units, at $10.00 per Unit. Also on December 9, 2020, pursuant to a provision of the sponsor warrant purchase agreement, the Company consummated the sale of an additional 900,000 Private Placement Warrants, at $1.00 per Private Placement Warrant. Combined sales of Units and Private Placement Warrants generated total gross proceeds of $30,900,000. A total of $30,300,000 of the net proceeds was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $232,300,000.

Transaction costs amounted to $11,166,437, consisting of $3,917,000 of underwriting fees, $6,854,750 of deferred underwriting fees and $394,687 of other offering costs.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-~~Business~~transaction ~~Combination~~ company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. ~~There is no assurance that the Company will be able to successfully complete a Business Combination.~~

The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.10 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 65) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.

Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination by May 24, 2022 (or until November 24, 2022 if the Company extends the period of time to consummate a Business Combination) and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period.

The Company will have until May 24, 2022 to complete a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination by May 24, 2022, the Company may extend the period of time to consummate a Business Combination by an additional six months (until November 24, 2022) to complete a Business Combination) (the “Combination Period”). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliate or designees must deposit into the Trust Account $2,300,000 ($0.10 per Public Share ~~in either case~~), on or prior to the date of the deadline. As of the date of the filing of these financial statements the company intends to dissolve and liquidate in accordance with the provisions of its amended and restated certificate of incorporation and will redeem all Public Shares, at a per-share redemption price of approximately $10.10.

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 76) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the amount of funds deposited into the Trust Account ($10.10).

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.10 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.10 per Public Share due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accountants), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

As of the date of the filing of these financial statements the company intends to dissolve and liquidate in accordance with the provisions of its amended and restated certificate of incorporation and will redeem all Public Shares, at a per-share redemption price of approximately $10.10.

Liquidity and Going Concern

As of ~~September~~March 3031, ~~2021~~2022, the Company had $~~479~~161,~~978~~ 294 in its operating bank accounts, $232,~~382~~393,~~820~~324 in marketable securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and a working capital deficit of $~~121~~1,~~480~~079,140 (after adding back $~~104~~50,~~098~~000 in franchise tax payable as that liability, which is included in accounts payable and accrued expenses in the accompanying March 31, 2022 condensed balance sheet, is allowed to be settled using the Trust Account).

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. As of the date of the filing of these financial statements the company intends to dissolve and liquidate in accordance with the provisions of its amended and restated certificate of incorporation and will redeem all Public Shares, at a per-share redemption price of approximately $10.10.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until May 24, 2022 to consummate the proposed Business Combination. ItA isBusiness ~~uncertain~~Combination ~~that~~will ~~the~~not ~~Company~~be consummated by May 24, 2022, so there will be ~~able~~a tomandatory ~~consummate~~liquidation ~~the~~and ~~proposed Business~~subsequent ~~Combination~~dissolution byof ~~this~~the ~~time~~Company. Additionally, the Company ~~may~~does not have sufficient liquidity to fund the working capital needs of the Company through one year from the issuance of these financial statements. ~~If a Business Combination is not consummated by this date, there~~ ~~will be a mandatory liquidation and subsequent dissolution of the Company.~~ Management has determined that the liquidity condition and mandatory liquidation, ~~should a Business Combination not occur, and potential subsequent dissolution,~~ raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after May 24, 2022. The Company intends to complete the proposed Business Combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate any Business Combination by May 24, 2022. In addition, the Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, the Company may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. the Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through the liquidation date of May 24, 2022.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of operations and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed financial statements. The accompanying condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

~~NOTE~~Additionally, 2as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. ~~RESTATEMENT~~In OFaddition, ~~PREVIOUSLY~~the ~~ISSUED~~Company’s ~~FINANCIAL~~ability ~~STATEMENTS~~to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

InAs ~~connection~~of ~~with~~ the ~~preparation~~date of the ~~Company’s financial~~filing ~~statements as~~ of ~~September~~these ~~30, 2021, management identified errors made in its historical~~ financial statements ~~where, at the~~ ~~closing of~~ the ~~Company’s~~company ~~Initial~~intends ~~Public Offering, the Company improperly valued its Class A common stock subject~~ to ~~possible~~dissolve ~~redemption. The~~and ~~Company~~liquidate ~~previously determined the Class A common stock subject to possible redemption to be equal to the redemption value, while also taking into consideration a redemption cannot result~~ in ~~net~~accordance ~~tangible~~with ~~assets being less than $5,000,001. Management determined that~~ the ~~Public~~ ~~Shares~~provisions ~~underlying the Units issued during the Initial Public Offering can be redeemed or become redeemable subject to the occurrence~~ of ~~future~~its ~~events~~amended ~~considered~~and ~~outside~~restated ~~the~~certificate ~~Company’s control. Therefore, management concluded that the redemption value should include all shares~~ of ~~Class A common stock subject to possible redemption, resulting in the Class A common stock subject to possible redemption~~incorporation ~~being~~and ~~equal~~will toredeem ~~their~~all ~~redemption~~Public ~~value. As a result~~Shares, ~~management~~at ~~has noted~~ a ~~reclassification~~per-share ~~error~~redemption ~~related~~price ~~to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value~~ of ~~the~~approximately ~~Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock~~$10.10.

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

~~The following tables summarize the effect of the restatement on each~~NOTE ~~financial~~2. ~~statement~~SUMMARY ~~line~~OF ~~items~~SIGNIFICANT asACCOUNTING ~~of the dates, and for the period, indicated:~~POLICIES

Balance Sheet as of November 24, 2020 (audited)	As Previously Reported			Adjustment			As Restated
Class A common stock subject to possible redemption	$	175,505,080		$	26,494,920		$	202,000,000
Class A common stock	$	262		$	(262	)	$	—
Additional paid-in capital	$	5,491,701		$	(5,491,701	)	$	—
Accumulated deficit	$	(492,533	)	$	(21,002,957	)	$	(21,495,490	)
Total Stockholders’ Equity (Deficit)	$	5,000,005		$	(26,494,920	)	$	(21,494,915	)
Class A common stock		2,623,259			(2,623,259	)		--
Class A common stock subject to possible redemption		17,376,741			2,623,259			20,000,000
Balance Sheet as of December 31, 2020 (audited)
Class A common stock subject to possible redemption	$	195,101,440		$	37,198,560		$	232,300,000
Class A common stock	$	368		$	(368	)	$	—
Additional paid-in capital	$	12,827,735		$	(12,827,735	)	$	—
Accumulated deficit	$	(7,828,675	)	$	(24,370,457	)	$	(32,199,132	)
Total Stockholders’ Equity (Deficit)	$	5,000,003		$	(37,198,560	)	$	(32,198,557	)
Class A common stock		3,682,737			(3,682,737	)		--
Class A common stock subject to possible redemption		19,317,263			3,682,737			23,000,000
Balance Sheet as of March 31, 2021 (unaudited)
Class A common stock subject to possible redemption	$	203,918,209		$	28,381,791		$	232,300,000
Class A common stock	$	281		$	(281	)	$	—
Additional paid-in capital	$	4,011,053		$	(4,011,053	)	$	—
Accumulated deficit	$	988,098		$	(24,370,457	)	$	(23,382,359	)
Total Stockholders’ Equity (Deficit)	$	5,000,007		$	(28,381,791	)	$	(23,381,784	)
Class A common stock		2,812,180			(2,812,180	)		--
Class A common stock subject to possible redemption		20,187,820			2,812,180			23,000,000
Balance Sheet as of June 30, 2021 (unaudited)
Class A common stock subject to possible redemption	$	200,803,116		$	31,496,884		$	232,300,000
Class A common stock	$	312		$	(312	)	$	—
Additional paid-in capital	$	7,126,115		$	(7,126,115	)	$	—
Accumulated deficit	$	(2,126,999	)	$	(24,370,457	)	$	(26,497,456	)
Total Stockholders’ Equity (Deficit)	$	5,000,003		$	(31,496,884	)	$	(26,496,881	)
Class A common stock		3,119,396			(3,119,396	)		--
Class A common stock subject to possible redemption		19,880,604			3,119,396			23,000,000
Statement of Operations for the Period from August 14, 2020 (inception) to December 31, 2020 (audited)
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption		18,957,421			(18,957,421	)		—
Basic and diluted weighted average shares outstanding, Non-redeemable common stock		5,931,349			(5,931,349	)		—
Basic and diluted net loss per share, Non-redeemable common stock	$	(1.32	)	$	1.32		$	—
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption		—			5,798,561			5,798,561
Basic and diluted net loss per share, Class A common stock subject to possible redemption		—			(0.72	)		(0.72	)
Basic and diluted weighted average shares outstanding, Class B common stock (non-redeemable)		—			5,126,923			5,126,923
Basic and diluted net loss per share, Class B common stock (non-redeemable)		—			(0.72	)		(0.72	)
Statement of Operations for the Three Months Ended March 31, 2021 (unaudited)
Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption		19,317,263			(19,317,263	)		—
Basic and diluted weighted average shares outstanding, Non-redeemable common stock		9,432,737			(9,432,737	)		—
Basic and diluted net income per share, Non-redeemable common stock	$	0.93		$	(0.93	)	$	—
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption		—			23,000,000			23,000,000
Basic and diluted net income per share, Class A common stock subject to possible redemption	$	—		$	0.31		$	0.31
Basic and diluted weighted average shares outstanding, Class B common stock (non-redeemable)		—			5,750,000			5,750,000
Basic and diluted net income per share, Class B common stock (non-redeemable)	$	—		$	0.31		$	0.31
Statement of Operations for the Three Months Ended June 30, 2021 (unaudited)
Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption		20,187,820			(20,187,820	)		—
Basic and diluted weighted average shares outstanding, Non-redeemable common stock		8,562,180			(8,562,180	)		—
Basic and diluted net loss per share, Non-redeemable common stock	$	(0.36	)	$	0.36		$	—
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption		—			23,000,000			23,000,000
Basic and diluted net loss per share, Class A common stock subject to possible redemption	$	—		$	(0.11	)	$	(0.11	)
Basic and diluted weighted average shares outstanding, Class B common stock (non-redeemable)		—			5,750,000			5,750,000
Basic and diluted net loss per share, Class B common stock (non-redeemable)	$	—		$	(0.11	)	$	(0.11	)
Statement of Operations for the Six Months Ended June 30, 2021 (unaudited)
Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption		19,754,946			(19,754,946	)		—
Basic and diluted weighted average shares outstanding, Non-redeemable common stock		8,995,054			(8,995,054	)		—
Basic and diluted net income per share, Non-redeemable common stock	$	0.63		$	(0.63	)	$	—
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption		—			23,000,000			23,000,000
Basic and diluted net income per share, Class A common stock subject to possible redemption	$	—		$	0.20		$	0.20
Basic and diluted weighted average shares outstanding, Class B common stock (non-redeemable)		—			5,750,000			5,750,000
Basic and diluted net income per share, Class B common stock (non-redeemable)	$	—		$	0.20		$	0.20
Statement of Changes in Stockholders’ Equity (Deficit) for the Period from August 14, 2020 (Inception) Through December 31, 2020 (audited)
Sale of 23,000,000 Units, net of underwriting discounts, offering costs and warrant liability	$	207,905,118		$	(207,905,118	)	$	—
Class A common stock subject to possible redemption	$	(195,101,440	)	$	195,101,440		$	—
Accretion for Class A common stock subject to redemption amount	$	—		$	(24,394,882	)	$	(24,394,882	)
Total stockholders’ equity (deficit)	$	5,000,003		$	(37,198,560	)	$	(32,198,557	)
Statement of Changes in Stockholders’ Equity (Deficit) for the for the Three Months ended March 31, 2021 (unaudited)
Change in value of Class A common stock subject to redemption	$	8,816,769		$	(8,816,769	)	$	—
Total stockholders’ equity (deficit)	$	5,000,007		$	(28,381,791	)	$	(23,381,784	)
Statement of Changes in Stockholders’ Equity (Deficit) for the for the Three Months ended June 30, 2021 (unaudited)
Change in value of Class A common stock subject to redemption	$	(3,115,093	)	$	3,115,093		$	—
Total stockholders’ equity (deficit)	$	5,000,003		$	(31,496,884	)	$	(26,496,881	)
Statement of Cash Flows for the Period from August 14, 2020 (inception) to December 31, 2020 (audited)
Initial classification of Class A common stock subject to possible redemption	$	202,355,084		$	(202,355,084	)	$	—
Change in value of Class A common stock subject to possible redemption	$	(7,253,644	)	$	7,253,644		$	—
Statement of Cash Flows for the Three Months Ended March 31, 2021 (unaudited)
Change in value of Class A common stock subject to possible redemption	$	8,816,769		$	(8,816,769	)	$	—
Statement of Cash Flows for the Six Months Ended June 30, 2021 (unaudited)
Change in value of Class A common stock subject to possible redemption	$	5,701,676		$	(5,701,676	)	$	—

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 (UNAUDITED)

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in ~~Amendment No. 1 to~~ the Annual Report on Form 10-K for the period ended December 31, ~~2020~~2021 filed with the SEC on ~~June~~March 29, ~~2021~~2022. The December 31, ~~2020~~ 2021 condensed balance sheet data was derived from audited financial statements. The operating results for the three ~~and nine~~ months ended ~~September~~ 30March 31, ~~2021~~2022 are not necessarily indicative of the results to be expected for the full year ending December 31, ~~2021~~2022.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act ~~of 2002~~, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that ana ~~emerging growth~~ company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

The Company will remain an emerging growth company until the earliest of (i) the last day of the first fiscal year (a) following the fifth anniversary of the completion of the Initial Public Offering, (b) in which the Company’s total annual gross revenue is at least $1.07 billion or (c) when the Company is deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30th and (ii) the date on which the Company has issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021.

Marketable Securities Held in Trust Account

At March ~~September~~31, 302022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in ~~money~~marketable ~~market funds~~securities, which are ~~invested~~ primarily in ~~U.S.~~money ~~Treasury~~market ~~securities.~~funds Atwhich ~~December 31,~~invest ~~2020, substantially all of the assets held~~ in ~~the Trust Account were in~~ U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance ~~sheet~~sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Offering Costs

Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock are included in Accretion for Class A common stock subject to redemption amount upon the completion of the Initial Public Offering.

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” ~~(“ASC~~Shares ~~480”).~~of Class A common stock subject to mandatory redemption ~~(if~~is ~~any) are~~ classified as a liability instrument and ~~are~~is measured at fair value. Conditionally redeemable ~~Class A~~ common stock (including ~~Class A~~ common stock that ~~feature~~ features redemption rights that ~~are~~is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) ~~are~~is classified as temporary equity. At all other times, common stock ~~are~~is classified as stockholders’ equity. The Company’s Class A common stock ~~feature~~features certain redemption rights that are considered to be outside of the Company’s control and subject to ~~the~~ occurrence of uncertain future events. Accordingly, at March ~~September 30~~31, ~~2021~~2022 and December 31, ~~2020~~2021, the 23,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value, which approximates fair value, at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid -in capital ~~and~~ (to the extent available), accumulated deficit and Class A common stock.

At ~~September 30, 2021 and~~ December 31, ~~2020~~2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:

Gross proceeds	$	230,000,000
Less:
Proceeds allocated to Public Warrants		(11,500,000	)
Class A common stock issuance costs		(10,594,882	)
Plus:
Accretion of carrying value to redemption value		24,394,882
Class A common stocks subject to possible redemption	$	232,300,000

There were no changes to the above during the three months ended March 31, 2022.

Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for the warrants issued in connection with our Initial Public Offering in accordance with the guidance contained in ASC 815-40-15-7D, under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our condensed statements of operations. The Private Placement Warrants and the Public Warrants (as described in Note 4) for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price on the New York Stock Exchange was used as the fair value of each relevant date.9

10CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS MARCH 31, 2022 (UNAUDITED)

~~CASCADE~~For ~~ACQUISITION~~issued ~~CORP~~or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required ~~NOTES~~to TObe ~~CONDENSED~~recorded ~~FINANCIAL~~at ~~STATEMENTS~~their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for ~~SEPTEMBER~~the 30warrants issued in connection with our Initial Public Offering in accordance with the guidance contained in ASC 815-40-15-7D, ~~2021~~under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our condensed statements of operations. The Private Placement Warrants and the Public Warrants (~~UNAUDITED~~as described in Note 3) for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price on the New York Stock Exchange was used as the fair value of each relevant date.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

~~The Financial Accounting Standards Board (“~~FASB”) ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The effective tax rate differs from the statutory tax rate of 21% for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2021~~2022 and ~~for the period from August 14~~2021, ~~2020 (inception) through September 30, 2020,~~ due to the valuation allowance recorded on the Company’s net operating losses and permanent differences related to the warrant liabilities.

On March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.

Net Income ~~(Loss)~~ per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income ~~(loss)~~ per common share is computed by dividing net income ~~(loss)~~ by the weighted average number of common stock outstanding for the period. ~~The Company applies the two-class method in calculating income (loss) per common share.~~ Accretion associated with the redeemable shares of Class A common stock is excluded from income ~~(loss)~~ per common share as the redemption value approximates fair value.

The calculation of diluted income ~~(loss)~~ per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants isbecause ~~contingent upon~~ the ~~occurrence~~inclusion of ~~future~~such ~~events~~warrants would be anti-dilutive. The warrants are exercisable to purchase 19,717,000 shares of Class A common stock in the aggregate. As of March ~~September 30~~31, ~~2021~~2022 and ~~2020~~December 31, 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income ~~(loss)~~ per common share is the same as basic net income ~~(loss)~~ per common share for the periods presented.

1110

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

The following table reflects the calculation of basic and diluted net income ~~(loss)~~ per common share (in dollars, except share amounts):

	Three Months Ended September 30, 2021				Nine Months Ended September 30, 2021				For the Period from August 14, 2020 (Inception) Through September 30, 2020
	Three Months Ended March 31, 2022				Three Months Ended March 31, 2021
	Class A		Class B		Class A		Class B		~~Class A~~		~~Class B~~
Basic and diluted net income (loss) per common share
Basic and diluted net income per common share
Numerator:
Allocation of net income (loss), as adjusted	$	5,491,186	$	1,372,797	$	10,052,527	$	2,513,132	$	—	$	(882	)
Allocation of net income, as adjusted	$	4,574,694	$	1,143,673	$	7,053,418	$	1,763,355
Denominator:
Basic and diluted weighted average shares outstanding		23,000,000		5,750,000		23,000,000		5,750,000		—		~~5,000,000~~
Basic and diluted net income (loss) per common share	$	0.24	$	0.24	$	0.44	$	0.44	$	—	$	(0.00	)
Basic and diluted net income per common share	$	0.20	$	0.20	$	0.31	$	0.31

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance ~~sheet~~sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 109).

Recent Accounting Standards

In August 2020, the FASB issued ~~Accounting Standards Update (“~~ASU”) 2020-06, Debt -- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU ~~ASU2020~~2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible ~~instruments~~ instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

1211

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

NOTE 4 3. INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 23,000,000 Units, inclusive of 3,000,000 Units sold to the underwriters on December 9, 2020 upon the underwriters’ election to fully exercise their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share (see Note 9 7).

NOTE 5 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,317,000 Private Placement Warrants at a price of $1.00 per private Placement Warrant, for an aggregate purchase price of $7,317,000 in a private placement. On December 9, 2020, in connection with the underwriters’ election to fully exercise their over-allotment option, the Company sold an additional 900,000 Private Placement Warrants to the Sponsor, at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $900,000. Each Private Placement Warrant is exercisable for one ~~share of~~ Class A common ~~stock~~share at a price of $11.50 per share, subject to adjustment (see Note 97). The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. IfThe ~~the~~ Company does not anticipate to complete a Business Combination within the Combination Period, so the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.

NOTE 6 5. RELATED PARTY TRANSACTIONS

Founder Shares

On August 24, 2020, the Company issued an aggregate of 7,187,500 shares of Class B common stock to the Sponsor for an aggregate purchase price of $25,000 in cash. In October 2020, the Sponsor returned to the Company, at no cost, an aggregate of 1,437,500 shares of Class B common stock, which the Company cancelled, resulting in an aggregate of 5,750,000 shares of Class B common stock (the “Founder Shares”) issued and outstanding. The Founder Shares included an aggregate of up to 750,000 shares of Class B common stock subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor will own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option on December 9, 2020, no Founder Shares are currently subject to forfeiture.

The Sponsor has agreed that, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.

1312

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

Promissory Note — Related Party

On August 14, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) March 31, 2021 or (i) the consummation of the Initial Public Offering. ~~The~~There ~~Company~~was ~~borrowed a total of~~ $172,046 outstanding under the Promissory Note, which was repaid on December 7, 2020. Borrowings are no longer available under the Promissory Note.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of ~~September~~March 3031, 2022 and December 31, 2021, the terms of the Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. Through the date of this filing, the Company has not made any borrowings under the Working Capital Loans.

Related Party Extension Loans

As discussed in Note 1, the Company may extend the period of time to consummate a Business Combination by an additional six months (until November 24, 2022 to complete a Business Combination). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees must deposit into the Trust Account $2,300,000 ($0.10 per Public Share), on or prior to the date of the deadline. Any such payments would be made in the form of a non-interest bearing, unsecured promissory note. Such notes would either be paid upon consummation of a Business Combination, or, at the relevant insider’s discretion, converted upon consummation of a Business Combination into additional Private Placement Warrants at a price of $1.00 per Private Warrant. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete a Business Combination.

1413

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

NOTE 7 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on November 19, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants issued upon conversion of the Working Capital Loans) will be entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

Jay Levine, the Company’s Chief Executive Officer, Gene Weil, a director of the Company, and certain affiliates of the Sponsor and Waterfall Asset Management, LLC purchased an aggregate of 2.75% of the Units in the Initial Public Offering, and certain other investors identified by the Sponsor purchased an aggregate of 14.3% of the Units in the Initial Public Offering, in each case at the Initial Public Offering price, for an aggregate of 3,415,000 Units. The underwriters did not receive any underwriting discounts or commissions on the Units purchased by such parties.

The underwriters are entitled to a deferred fee of $0.35 per Unit, excluding the Units purchased by the parties described above, or $6,854,750 in the aggregate which is included in the accompanying condensed balance sheets. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Consulting Agreement

On January 30, 2021, the Company entered into a consulting agreement with a service provider, pursuant to which the service provider will provide the Company with consulting services in connection with our search for a potential merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The Company agreed to pay the service provider an initial fee of $41,668 and $20,834 per month thereafter up to a period of 16 months. ~~Total~~ ~~expense, which is included in the accompanying condensed statements of operations, were $10,417 and $156,255 for the three and nine months ended September 30, 2021, respectively.~~ Effective August 13, 2021, the Company terminated the agreement and no further fees were due upon termination.

1514

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

NOTE 8 7. STOCKHOLDERS’ ~~EQUITY~~DEFICIT

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021, there were no shares of preferred stock issued or outstanding.

Class A Common ~~stock~~Stock — The Company is authorized to issue 200,000,000 shares of Class A common stock, with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021, there were 23,000,000 shares of common stock subject to possible redemption, which are presented as temporary equity.

Class B Common ~~stock~~Stock — The Company is authorized to issue 20,000,000 shares of Class B common stock, with a par value of $0.0001 per share. Holders of the Class B common stock are entitled to one vote for each share. At ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021, there were 5,750,000 shares of Class B common stock issued and outstanding.

Holders of ~~the~~ Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.

The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the consummation of a Business Combination at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of shares of common stock issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of (a) all shares of common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or deemed issued by the Company in connection with or in relation to the completion of a Business Combination, excluding (1) any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in a Business Combination and any (2) Private Placement Warrants issued to the Sponsor or any of its affiliates upon conversion of Working Capital Loans minus (b) the number of Public Shares redeemed by Public Stockholders in connection with a Business Combination. In no event will the shares of our Class B common stock convert into shares of our Class A common stock at a rate of less than one to one.

NOTE 9 8. WARRANTS

As of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021, the Company had 11,500,000 Public Warrants and 8,217,000 Private Placement Warrants outstanding.

Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a ~~Public~~warrant ~~Warrant~~ and will have no obligation to settle such ~~Public~~warrant ~~Warrant~~ exercise unless a registration statement under the Securities Act ~~covering~~with ~~the~~respect ~~issuance~~to of the Class A common stock ~~issuable upon exercise of~~ underlying the warrants is then effective and a ~~current~~ prospectus relating thereto is ~~available~~current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable ~~for cash or on a cashless basis,~~ and the Company will not be obligated to issue ~~any~~a ~~shares~~share toof ~~holders~~Class ~~seeking~~A tocommon stock upon exercise ~~their~~of ~~warrants,~~a warrant unless the ~~issuance~~share of ~~the~~Class ~~shares~~ A common stock issuable upon such warrant exercise ishas been registered, qualified or ~~qualified~~deemed to be exempt under the securities laws of the state of ~~the~~residence ~~exercising~~of the registered holder, orof anthe ~~exemption is available~~warrants.

1615

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

The Company has agreed that as soon as practicable, but in no event later than 1520 business days after the closing of a Business Combination, the itCompany will use its commercially reasonable efforts to file with the SEC a registration statement ~~covering~~for the ~~issuance~~registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants,. ~~and~~The ~~the~~ Company will use its commercially reasonable efforts to cause the same to become effective ~~within 60 business days after the closing of a Business Combination~~ and to maintain the effectiveness of such registration statement, and a current ~~prospectus~~ prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. ~~Notwithstanding~~If a registration statement covering the ~~above~~issuance of the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, ifwarrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the Class A common stock are, at the time of any exercise of a warrant, not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of ~~public~~the ~~warrants~~Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects to do so, the Company will not be required to file or maintain in effect a registration statement, but the Company will use its ~~commercially~~best ~~reasonable~~ efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of Warrants When the Price per share of Class A Common ~~stock~~Stock Equals or Exceeds $18.00. — Once the ~~warrants~~Public Warrants become exercisable, the Company may redeem the ~~outstanding~~ Public Warrants (except with respect to the Private Placement Warrants):

● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder and ● if, and only if, the last reported sale price of the Class A common stock for any 20 trading days within a 30-trading day period ending onthree ~~the~~business ~~third~~days ~~trading~~before ~~day prior to~~ the ~~date on which the~~ Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted).

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of Warrants When the Price per share of Class A Common Stock Equals or Exceeds $10.00. — Once the warrants become exercisable, the Company may redeem the outstanding warrants:

●

in whole and not in part;

● at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Class A common stock; ~~and~~

● if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted).; and

●

if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.

If the Company calls the Public Warrants for redemption, management will have the option to require any holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the ~~Public~~warrants ~~Warrants~~ may be adjusted in certain circumstances including in the event of a ~~share~~stock dividend, ~~extraordinary~~ ~~dividend~~ or recapitalization, reorganization, merger or consolidation. However, except as described below, the ~~Public~~warrants ~~Warrants~~ will not be adjusted for ~~issuances~~issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the ~~Public Warrants~~warrants. IfThe ~~the~~ Company isdoes ~~unable~~not expect to complete a Business Combination within the Combination Period and the Company plans to liquidates the funds held in the Trust Account, and therefore the holders of ~~Public~~warrants ~~Warrants~~ will not receive any of such funds with respect to their ~~Public Warrants~~warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such ~~Public Warrants~~warrants. Accordingly, the ~~Public~~warrants ~~Warrants~~ may expire worthless.

1716

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the ~~its~~Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates ~~its~~a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger ~~price~~prices will be adjusted (to the nearest cent) to be equal to ~~180~~100% of ~~the~~and ~~higher~~180% of the ~~Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the~~ higher of the Market Value and the Newly Issued Price, respectively.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company; (2) they (including the common stock issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of a Business Combination; (3) they may be exercised by the holders on a cashless basis; (4) they (including the common stock issuable upon exercise of these warrants) are entitled to registration rights; and (5) they can only be exercised during the period (A) commencing on the later of: (i) the date that is thirty (30) days after the first date on which the Company completes its Business Combination, and (ii) the date that is twelve (12) months from the date of the closing of the Initial Public Offering, and (B) terminating at the earliest to occur of (x) 5:00 p.m., New York City time on the date that is seven years after the date on which the Company completes its Business Combination, and (y) the liquidation of the Company in accordance with the Company’s Amended and Restated Certificate of Incorporation, as amended from time to time, if the Company fails to complete a Business Combination.

NOTE 10 9. FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:

Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:

Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:

Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

1817

CASCADE ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022 (UNAUDITED)

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~ 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description	Level		~~September~~March 3031, ~~2021~~2022		~~Level~~December 31, 2021		~~December 31, 2020~~
Assets:
Marketable securities held in Trust Account		1	$	232,~~382~~393,~~820~~324	$	1232,387,376	$	~~232,296,529~~
Liabilities
Warrant Liability – Public Warrants		1	$	7,130,000		3	$	15,640,000
Warrant Liabilities – Public Warrants		1	$	2,070,000	$	5,750,000
Warrant Liability – Private Placement Warrants		2	$	5,505,390		3	$	11,175,120
Warrant Liabilities – Private Placement Warrants		2	$	1,479,060	$	4,108,500

The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the accompanying balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the change in fair value of warrant liabilities in the statements of operations.

~~The Public Warrants and Private Placement Warrants~~NOTE ~~were valued as of November 24, 2020 and December 31, 2020 using a Monte Carlo simulation, which is considered to be a Level 3 fair value measurement~~10. SUBSEQUENT The Monte Carlo simulation’s primary unobservable input utilized in determining the fair value of the Warrants is the probability of consummation of the Business Combination. The probability assigned to the consummation of the Business Combination was 90%, which was estimated based on the observed success rates of business combinations for special purpose acquisition companies. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target.EVENTS

The following table presents the quantitative information regarding Level 3 fair value measurements at December 31, 2020:

Expected volatility		23.0	%
Risk-free interest rate		0.52	%
Expected term (years)		5.42
Fair value per share of Class A common stock	$	10.45

The subsequent measurements of the Public Placement Warrants after the detachment of the Public Placement Warrants from the Units are classified as Level 1 due to the use of the quoted price in an active market (the New York Stock Exchange) under the ticker CAS.WS. For the Private Placement Warrants, because of the provision in the Public and Private Placement Warrant agreements described in Note 8 regarding the Company’s ability to redeem the warrants when the trading price of the warrants equals or exceeds $10.00, the Company concluded the fair value of the Public and Private Placement Warrants to be equal. Therefore, subsequent measurements of the fair value of the Private Placement Warrants are also determined by using the quoted price in an active market under the ticker CAS. WS, which for the Private Warrants is a Level 2 measurement.

The following table presents the changes in the fair value of Level 3 warrant liabilities:

	Private Placement			Public			Warrant Liabilities
Fair value as of January 1, 2021	$	11,175,120		$	15,640,000		$	26,815,120
Transfers to Level 1		—			(15,640,000	)		(15,640,00	)
Transfers to Level 2		(11,175,120	)		—			(11,175,120	)
Fair value as of September 30, 2021	$	—		$	—		$	—

Transfers in the amount of $15,640,000 from Level 3 to Level 1, and transfers in the amount of $11,175,120 from Level 3 to Level 2 of the fair value hierarchy occurred during the nine months ended September 30, 2021. There were no transfers between fair value levels during the three months ended September 30, 2021.

NOTE 11. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

19On May 18, 2022, the Company issued a press release announcing that the Company intends to dissolve and liquidate in accordance with the provisions of its amended and restated certificate of incorporation and will redeem all of its Public Shares.

Due to the Company’s inability to consummate an initial business combination within the time period required by its amended and restated certificate of incorporation, the Company intends to dissolve and liquidate in accordance with the provisions of its amended and restated certificate of incorporation and will redeem all Public Shares, at a per-share redemption price of approximately $10.10. As of the close of business on May 24, 2022, the Public Shares represent only the right to receive the redemption amount.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us,” “Cascade” or the “Company” refer to Cascade Acquisition Corp. References to our “management” refer to our officers and directors, and references to the “Sponsor” refer to Cascade Acquisition Holdings, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s ~~Amendment No 1 to the~~ Annual Report on Form 10-K/A for the year ended December 31, 2021 ~~2020~~ filed with the U.S. Securities and Exchange Commission (the “SEC”) on ~~June~~March 29, ~~2021~~2022. The Company’s ~~securities~~ securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable ~~securities~~ securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations has been amended and restated to give effect to the restatement of our financial statements as of December 31, 2020, March 31, 2021 and June 30, 2021. Management identified errors made in its historical financial statements where, at the closing of the Company’s initial public offering (“Initial Public Offering”), the Company improperly valued its Class A common stock subject to possible redemption. The Company previously determined the Class A common stock subject to possible redemption to be equal to the redemption value, while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Management determined that the ~~Public~~shares ~~Shares~~of Class A common stock underlying the ~~Units~~units issued during the Initial Public Offering (the “Unit”) can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore, management concluded that the redemption value should include all shares of Class A common stock subject to possible redemption, resulting in the Class A common stock subject to possible redemption being equal to their redemption value. As a result, management has noted a reclassification error related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.

Overview

We are a blank check company ~~incorporated~~formed inunder the laws of the State of Delaware on August 14, 2020 ~~formed~~ for the purpose of effecting a merger, ~~amalgamation,~~capital ~~share~~stock exchange, asset acquisition, ~~share~~stock purchase, reorganization or other similar ~~Business~~business ~~Combination~~combination with one or more businesses. We intend to effectuate our ~~Business~~initial ~~Combination~~business ~~using~~combination using cash ~~derived~~ from the proceeds of the ~~Initial~~initial ~~Public~~public ~~Offering~~offering and the sale of the private placement warrants (the “Private Placement Warrants”), our ~~shares~~capital stock, debt or a combination of cash, ~~shares~~stock and debt.

WeAs ~~expect~~of tothe ~~continue~~date toof ~~incur~~the ~~significant~~filing ~~costs~~of these financial statements the company intends to dissolve and liquidate in accordance with the ~~pursuit~~provisions of ~~our~~its ~~acquisition~~amended ~~plans.~~and Werestated ~~cannot~~certificate ~~assure~~of ~~you~~incorporation and will redeem all of the shares of outstanding common stock that ~~our~~were ~~plans~~included toin ~~complete~~the units issued in its initial public offering (the “Public Shares”), at a ~~Business~~per-share ~~Combination~~redemption ~~will~~price beof ~~successful~~approximately $10.10.

2019

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. All activity through ~~September~~March 3031, ~~2021~~2022 relates to ~~the~~our ~~Company’s~~ formation and the initial public offering, which is described below, and the search for a target for its initial ~~Business~~business ~~Combination~~combination. We do not expect to generate any operating revenues until after the completion of aan ~~Business~~initial ~~Combination~~business combination, at the earliest. We generated and will continue to generate non-operating income in the form of interest income and unrealized gains or losses on marketable securities held in the ~~Trust~~trust ~~Account~~account. We incurred ~~will~~and will continue to incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, aan ~~Business~~initial ~~Combination~~business combination, along with income or loss from changes in the fair value of the warrant liabilities. As of the date of the filing of these financial statements the company intends to dissolve and liquidate in accordance with the provisions of its amended and restated certificate of incorporation and will redeem all Public Shares, at a per-share redemption price of approximately $10.10.

For the three months ended ~~September~~March 3031, ~~2021~~2022, we we had net income of $65,~~863~~718,~~983~~367, which consists of the change in fair value of warrant liabilities of $76,~~163~~309,~~780~~440, ~~and~~ interest earned on ~~marketable~~ marketable securities held in the Trust Account of $280,~~990~~637 and unrealized gain on marketable securities held in Trust Account of $12,311, offset by ~~operational~~formation and operating costs of $~~302~~684,~~787~~021.

For the ~~nine~~three months ended ~~September~~March 3031, 2021, we we had net income of $128,~~565~~816,~~659~~773, which consisted of the change in fair value of warrant liabilities of $149,~~179~~069,~~730~~820, ~~and~~ interest earned on marketable securities held in the Trust Account of $8658,~~291~~062, ~~offset~~and unrealized gain on marketable securities held in Trust Account of $19,592, offset by ~~operational~~formation and operating costs of $1330,~~700,362~~701.

~~For~~Liquidity ~~the period from August 14, 2020 (inception) through September 30, 2020, we had a net loss of $882, which consisted of formation~~ and ~~operational~~Capital ~~costs.~~Resources

Liquidity and Going Concern

On November 24, 2020, we consummated the Initial Public Offering of 20,000,000 Units at a price of $10.00 per Unit, generating gross proceeds of $200,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 7,317,000 Private Placement Warrants to the Sponsor at a price of $1.00 per Private Placement Warrant generating gross proceeds of $7,317,000.

On December 9, 2020, in connection with the underwriters’ election to fully exercise of their over-allotment option, we consummated the sale of an additional 3,000,000 Units and the sale of an additional 900,000 Private Placement Warrants, generating total gross proceeds of $30,900,000.

Following the ~~Initial~~initial ~~Public~~public ~~Offering~~offering, the full exercise of the over-allotment option by the underwriters’ and the sale of the Private Placement Warrants, a total of $232,300,000 was placed in the ~~Trust~~trust ~~Account and we had $1,782,072 of cash held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes~~account. We incurred $11,166,437 in transaction costs, including $3,917,000 of underwriting fees, $6,854,750 of deferred underwriting fees and $394,687 of other offering costs.

For the ~~nine~~three months ended ~~September~~March 3031, ~~2021~~2022, ~~cash~~ cash used in operating activities was $~~797~~304,~~730~~752. Net income of $125,~~565~~718,~~659~~367 was affected by the change in fair value of warrant liabilities of of $146,~~179~~309,~~730~~440, ~~and~~ interest earned on marketable securities held in the Trust Account of $8680,~~291~~637 and unrealized gain on marketable securities held in the Trust Account of $12,311. Changes in operating assets and liabilities provided $~~902~~379,~~632~~269 of cash for operating activities.

For the ~~period~~three ~~from~~months ~~August~~ended ~~14,~~March ~~2020 (inception) through September 30~~31, ~~2020~~2021, cash used in operating activities was $4169,630. Net loss of $~~882~~8,816,773 was affected by the ~~changes~~interest earned on marketable securities held in the Trust Account of $58,062, the unrealized gain on marketable securities held in the Trust Account of $19,592, and the change in fair value of warrant liabilities of $9,069,820. Changes in operating assets and liabilities which provided $~~878~~161,071 of cash for operating activities.

As of March 31, 2022, we had marketable securities held in the trust account of $232,393,324. As of the date of the filing of these financial statements the company intends to dissolve and liquidate in accordance with the provisions of its amended and restated certificate of incorporation and will redeem all Public Shares, at a per-share redemption price of approximately $10.10. We may withdraw interest from the trust account to pay taxes, if any, and up to $100,000 of interest to pay dissolution expenses. Through March 31, 2022, we have withdrawn $87,000 of interest earned on the trust account to pay our taxes. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete an initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of March 31, 2022, we had cash of $161,294, and a working capital deficit of $1,079,140 (after adding back $50,000 in franchise tax payable as that liability, which is included in accounts payable and accrued expenses in the accompanying condensed balance sheet, is allowed to be settled using interest accrued on funds in the trust account).

In order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, our sponsor, an affiliate of our sponsor, or our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we would repay such loaned amounts. In the event that an initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. The loans would be repaid upon consummation of an initial business combination, without interest. As of the date of the filing of these financial statements the company intends to dissolve and liquidate in accordance with the provisions of its amended and restated certificate of incorporation and will redeem all Public Shares, at a per-share redemption price of approximately $10.10.

In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” we have until May 24, 2022 to consummate the proposed initial business combination. A Business Combination will not be consummated by May 24, 2022 so there will be a mandatory liquidation and subsequent dissolution of the Company. Additionally, the Company does not have sufficient liquidity to fund the working capital needs of the Company through one year from the issuance of these financial statements. Management has determined that the liquidity condition and mandatory liquidation, raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we liquidate after May 24, 2022.

As of September 30, 2021, we had cash and marketable securities held in the Trust Account of $232,382,820. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, which interest shall be net of taxes payable and excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any (less up to $100,000 of interest to pay dissolution expenses). Through September 30, 2021, we did not withdraw any interest earned on the Trust Account to pay our taxes. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of September 30, 2021, we had cash of $479,978, and a working capital deficit of $121,480 (after adding back $104,098 in franchise tax payable as that liability, which is included in accounts payable and accrued expenses in the accompanying condensed balance sheet, is allowed to be settled using the Trust Account). We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. The loans would be repaid upon consummation of a Business Combination, without interest.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until May 24, 2022 to consummate the proposed Business Combination. It is uncertain that the Company will be able to consummate the proposed Business Combination by this time. Additionally, the Company may not have sufficient liquidity to fund the working capital needs of the Company through one year from the issuance of these financial statements. If a business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a business combination not occur, and potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after May 24, 2022. The Company intends to complete the proposed Business Combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate any business combination by May 24, 2022. In addition, the Company may need to raise additional capital through loans or additional investments from our Sponsor, stockholders, officers, directors or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, the Company may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through the liquidation date of May 24, 2022.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of ~~September~~March 3031, ~~2021~~2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

Jay Levine, our Chief Executive Officer, Gene Weil, a director, and certain affiliates of our Sponsor and Waterfall Asset Management, LLC purchased an aggregate of 2.75% of the Units in the Initial Public Offering, and certain other investors identified by our Sponsor purchased an aggregate of 14.3% of the Units in the Initial Public Offering, in each case at the Initial Public Offering price, for an aggregate of 3,415,000 Units. The underwriters did not receive any underwriting discounts or commissions on the Units purchased by such parties.

The underwriters are entitled to a deferred fee of $0.35 per Unit, excluding ~~the~~ Units purchased by the parties described above, or $6,854,750 in the aggregate. Subject to the terms of the underwriting agreement, (i) the deferred fee will be placed in the ~~Trust~~trust ~~Account~~account and released to the underwriters only upon the completion of aan ~~Business~~initial ~~Combination~~business combination and (ii) the deferred fee will be waived by the underwriters in the event that we do not complete aan initial ~~Business~~business ~~Combination~~combination. Up to 50% of the deferred underwriting commissions may be paid at the sole discretion of its management team to the underwriters in the allocations determined by its management team and/or to third parties not participating in the ~~Initial~~initial ~~Public~~public ~~Offering~~offering (but who are members of the Financial Industry Regulatory Authority) that assist us in consummating our initial ~~Business~~business ~~Combination~~combination.

On January 30, 2021, we entered into a consulting agreement with a service provider, pursuant to which the service provider will provide us with consulting services in connection with our search for a potential merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. We agreed to pay the service provider an initial fee of $41,668 and $20,834 per month thereafter up to a period of 16 months. ~~Effective August~~On August 13, 2021, we terminated ~~the~~such agreement. ~~An aggregate of $156,255 was paid under the agreement, and no further fees are due upon termination.~~

2322

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Class A Common Stock Subject to Possible Redemption

We account for our shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the ~~shares of~~ Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ ~~equity~~ ~~section~~deficit section of our condensed balance sheets.

Warrant Liabilities

~~The~~We ~~Company~~do ~~does~~ not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. ~~The~~We ~~Company~~account ~~accounts~~ for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants ~~are~~ are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to ~~the~~our ~~Company’s~~ own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of ~~the~~our ~~Company’s~~ control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. ~~The~~We ~~Company~~account ~~accounts~~ for the ~~warrants~~ warrants issued in connection with our ~~Initial~~initial ~~Public~~public ~~Offering~~offering in accordance with the guidance contained in ASC 815-40-15-7D, under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, ~~the~~we ~~Company~~classify ~~classifies~~ the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our ~~condensed~~ statements of operations. The Private Placement Warrants and the ~~Public~~warrants ~~Warrants~~included ~~(as~~in ~~described~~the inUnits ~~Note~~(the 9“public warrants”) for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the ~~Public~~public ~~Warrants~~warrants from the Units, the ~~Public~~public ~~Warrant~~warrant quoted market price on the New York Stock Exchange was used as the fair value of each relevant date.

24Net Income Per Common Share

Net ~~Income~~income ~~(Loss)~~per ~~Per~~common ~~Common~~share ~~Share~~is computed by dividing net income by the weighted average number of common stock outstanding for the period. Accretion associated with the redeemable shares of Class A common stock is excluded from income per common share as the redemption value approximates fair value.

Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating income (loss) per common share. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share as the redemption value approximates fair value.23

Recent Accounting ~~Pronouncements~~Standards

In August 2020, the Financial Accounting Standards Board (“FASB”) issued ~~Accounting Standards Update (“~~ASU”) 2020-06, Debt -- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. ~~The Company~~We isare currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Factors That May Adversely Affect Our Results of Operations

Our results of operations and our ability to complete an initial business combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial business combination.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not required for smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

WeDisclosure ~~maintain disclosure~~ controls ~~and~~are procedures that are designed with tothe ~~ensure~~objective of ensuring that information required to be disclosed in ~~the~~our reports ~~that~~filed ~~we file or submit~~ under the ~~Securities and~~ Exchange Act ~~of 1934~~ is ~~(1)~~ recorded, processed, summarized, and reported within the time ~~periods~~period specified in the SEC’s rules and forms. ~~and~~Disclosure ~~(2)~~ controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including ~~our~~the ~~principal~~chief executive officer and ~~our~~chief ~~principal~~ financial officer, as appropriate to allow timely decisions regarding required disclosure.

As ~~of September~~required ~~30,~~by ~~2021,~~Rules ~~our~~13a-15 ~~management, with~~and ~~the~~15d-15 ~~participation~~under ofthe Exchange Act, our ~~principal~~Chief ~~executive~~Executive ~~officer~~Officer and ~~principal~~Chief ~~financial~~Financial ~~officer,~~Officer ~~evaluated~~carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the ~~Securities~~Exchange Act) ~~and~~were ~~Exchange~~not ~~Act~~effective, ofdue ~~1934).~~to ~~Our management~~the ~~recognizes~~material ~~that~~weakness ~~any~~in ~~controls~~our ~~and~~internal ~~procedures,~~control noover ~~matter~~financial ~~how~~reporting ~~well~~related ~~designed~~to ~~and~~our ~~operated~~accounting for complex financial instruments. As a result, ~~can~~we ~~provide~~performed ~~only~~additional ~~reasonable~~analysis ~~assurance~~as deemed necessary to ensure that our financial statements were ofprepared ~~achieving~~in ~~their~~accordance ~~objectives,~~with ~~and~~GAAP. Accordingly, management ~~necessarily~~believes ~~applies~~that ~~its~~the ~~judgment~~financial statements included in ~~evaluating~~this ~~the~~Annual ~~cost-benefit~~Report present ~~relationship~~fairly in all material respects our financial position, results of ~~possible controls~~operations and ~~procedures~~cash flows for the period presented.

~~Based~~Management ~~upon~~has ~~the~~identified ~~evaluation,~~a ~~our~~material ~~principal executive~~weakness ~~officer~~in ~~and~~internal ~~principal~~controls ~~financial~~related ~~officer~~to ~~concluded~~the ~~that,~~accounting asfor ofcomplex ~~September~~financial ~~30,~~instruments. ~~2021,~~While ~~our~~we ~~disclosure~~have ~~controls~~processes ~~and~~to ~~procedures~~identify ~~were~~and ~~not effective~~appropriately asapply aapplicable ~~result~~accounting ofrequirements, ~~the~~we ~~material~~plan ~~weakness~~to ~~that~~continue ~~existed~~to inenhance our ~~internal~~system ~~control~~of ~~over~~evaluating ~~financial~~and ~~reporting~~implementing ~~related to~~ the ~~Company’s~~ accounting standards ~~for~~that ~~complex~~apply ~~financial~~to ~~instruments.~~our Asfinancial ~~a result~~statements, weincluding ~~performed~~through ~~additional~~enhanced ~~analysis~~analyses asby ~~deemed necessary to ensure that~~ our ~~financial~~personnel ~~statements were~~and ~~prepared~~third-party inprofessionals ~~accordance~~ with ~~U.S.~~whom ~~generally~~we consult ~~accepted~~regarding complex accounting ~~principles~~applications. ~~Accordingly,~~The ~~management~~elements ~~believes~~of ~~that~~our ~~the~~remediation ~~financial~~plan ~~statements included in~~can ~~this~~only ~~Form~~be ~~10-Q~~accomplished ~~present~~over ~~fairly~~time, inand ~~all~~we ~~material~~can offer ~~respects~~no ~~our~~assurance ~~financial~~that ~~position,~~these ~~results~~initiatives ofwill ~~operations~~ultimately ~~and~~have ~~cash flows for~~ the ~~period~~intended ~~presented~~effects.

Management has implemented remediation steps to improve our internal control over financial reporting. Specifically, we expanded and improved our review process for complex securities and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

Changes in Internal Control over Financial Reporting

~~During~~There ~~the most recently completed fiscal quarter, there~~ were no ~~change~~changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. In light of the restatement of our financial statements included in our Form 10-K/A, we plan to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

2624

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

Factors that could cause our actual results to ~~differ~~ differ materially from those in this Quarterly Report ~~on Form 10-Q~~ are any of the risks described in ~~Part~~our Ifinal prospectus, ~~Item~~dated 1ANovember 19, ~~Risk~~2020, filed ~~Factors~~with ofthe SEC on the same day, our quarterly report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the SEC on November 15, 2021, and Amendment No. 2 to our Annual report on Form 10-K/A for the fiscal year ended December 31, 2020, filed with the SEC on ~~June~~December 2930, 2021. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Except for the one set forth below, additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. ~~As of the date of this Quarterly Report on Form 10-Q, except for the risk set forth below, there have been no material changes to the risk factors disclosed in our Form 10-K/A.~~

WeMilitary ~~have~~conflict ~~identified a material weakness~~ in ~~our internal~~Ukraine ~~control~~could ~~over financial reporting as of September 30, 2021. If we are unable to develop and maintain an effective system of internal~~make ~~control~~it ~~over~~more ~~financial~~difficult ~~reporting,~~for weus ~~may not be able~~ to ~~accurately~~consummate ~~report our financial results in~~ a ~~timely manner, which may adversely affect investor confidence in us and materially and adversely affect our~~ business ~~and operating results~~combination.

~~After~~Military ~~consultation~~conflict ~~with our management, our audit committee identified,~~ in ~~light~~Ukraine ofmay ~~the~~lead ~~prior reclassification of warrants from equity~~ to ~~liability, as well as the reclassification of~~increased ~~our~~and ~~redeemable~~price ~~Class~~volatility Afor ~~common~~publicly ~~stock~~traded assecurities, ~~temporary~~including ~~equity~~ours, aand ~~material~~to ~~weakness~~other innational, ~~our~~regional ~~internal~~and ~~controls~~international ~~over~~economic ~~financial reporting relating~~disruptions toand ~~our~~economic ~~accounting for complex financial instruments. A material weakness is a deficiency~~uncertainty, orany ~~a combination~~ of ~~deficiencies,~~which incould ~~internal control~~make ~~over~~it ~~financial~~more ~~reporting~~difficult ~~such~~for ~~that~~us ~~there~~to isidentify a ~~reasonable~~business ~~possibility~~combination ~~that~~partner aand ~~material~~consummate ~~misstatement of our annual or interim financial~~a ~~statements~~business ~~will~~combination ~~not~~on beacceptable ~~prevented,~~commercial terms or ~~detected~~at ~~and corrected on a timely basis~~all.

Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. Measures to remediate material weaknesses may be time-consuming and costly and there is no assurance that such initiatives will ultimately have the intended effects. If we identify any new material weaknesses in the future, any such newly identified material weakness could limit our ability to prevent or detect a misstatement of our accounts or disclosures that could result in a material misstatement of our annual or interim financial statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting and our share price may decline. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to avoid potential future material weaknesses.25

AsRecent aincreases ~~result of the material weakness~~ in ~~our~~inflation ~~internal controls over financial reporting described above, the change~~ in ~~accounting for our warrants and redeemable Class A common stock, and other matters raised or that may in~~ the ~~future be raised by the SEC, we may face for the prospect of litigation or other disputes which~~United ~~may~~States ~~include, among others, claims invoking the federal~~ and ~~state~~elsewhere ~~securities~~could ~~laws,~~make ~~contractual~~it ~~claims~~more ordifficult ~~other~~for ~~claims~~us ~~arising from the material weaknesses in our internal control over financial reporting and the preparation of our financial statements, any of which claims could result in adverse effects~~ to ~~our~~consummate a business. ~~As of the date hereof, we have no knowledge of any such litigation or dispute~~combination.

Recent increases in inflation in the United States and elsewhere may be leading to increased price volatility for publicly traded securities, including ours, and may lead to other national, regional and international economic disruptions, any of which could make it more difficult for us to consummate a business combination.

Changes in laws or regulations or in how such laws or regulations are interpreted or applied, or a failure to comply with any laws, regulations, interpretations or applications, may adversely affect our business, including our ability to negotiate and complete our initial business combination.

We are subject to the laws and regulations, and interpretations and applications of such laws and regulations, of national, regional, state and local governments and applicable non-U.S. jurisdictions. In particular, our consummation of a business combination may be contingent upon our ability to comply with certain laws, regulations, interpretations and applications, and any post-business combination company may be subject to additional laws, regulations, interpretations and applications. Compliance with the foregoing may be difficult, time consuming and costly. Laws and regulations and their interpretation and application may also change from time to time, and those changes could have a material adverse effect on our business, including our ability to negotiate and complete an initial business combination. A failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete an initial business combination.

On March 30, 2022, the SEC issued proposed rules relating to, among other items, disclosures in business combination transactions involving special purpose acquisition companies (“SPACs”) and private operating companies; the financial statement requirements applicable to transactions involving shell companies; the use of projections in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to regulation under the Investment Company Act, as amended, including a proposed rule that would provide SPACs a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a SPAC’s duration, asset composition, business purpose and activities. These rules, if adopted, whether in the form proposed or in a revised form, may increase the costs of and the time needed to negotiate and complete an initial business combination, and may constrain the circumstances under which we could complete an initial business combination.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Use of Proceeds

On November 24, 2020, we consummated our Initial Public Offering of 20,000,000 units and issued an additional 3,000,000 units on December 9, 2020 pursuant to the exercise of the underwriters’ over-allotment option in fullNone. Each unit consists of one public share and one-half of one public warrant, with each whole public warrant entitling the holder thereof to purchase one public share for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $230,000,000.

We paid a total of $3,917,000 in underwriting discounts and commissions, excluding a deferred underwriting discount of $6,854,750 and approximately $394,687 for other costs and expenses related to the Initial Public Offering.

A total of $232,300,000, comprised of the net proceeds from the Initial Public Offering, the sale of over-allotment units, and a portion of the proceeds from the sale of the private placement warrants, was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental, acting as trustee. The proceeds held in the trust account may be invested by the trustee only in U.S. government securities with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

2726

ITEM 6. EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.		Description of Exhibit
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document.
101.SCH*		Inline XBRL Taxonomy Extension Schema Document.
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith.

**	Furnished.

2827

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CASCADE ACQUISITION CORP.
Date: November 15, 2021		/s/ Jay Levine
Date: May 20, 2022		/s/ Jay Levine
	Name:	Jay Levine
	Title:	Chief Executive Officer
		(Principal Executive Officer)
Date: November 15, 2021		/s/ Daniel Hirsch
Date: May 20, 2022		/s/ Daniel Hirsch
	Name:	Daniel Hirsch
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

2928

Filing Compare · Cascade Acquisition Corp